Golden Helix VSClinical

Apr 09, 2018

Golden Helix announced today the upcoming commercial launch of its VSClinical in May 2018. VSClinical will help labs automate their clinical interpretation of variants based on ACMG guidelines. In addition, the firm claims that VSClinical will eliminate problems with human error and individual subjectivity, as well as reduce the time and effort required to sign off on clincal reports. 

More Like This

Jan 22, 2019

Intermountain Healthcare Precision Genomics ICG100 Myeloid Malignancies Panel

Intermountain Healthcare Precision Genomics has announced its ICG100 Myeloid Malignancies Panel to help classify and diagnose multiple blood cancer types. The panel includes 63 genes and uses peripheral blood, bone marrow aspirate, extracted DNA, or fixed samples to detect faulty gene alterations through next-generation sequencing. According to Intermountain, the panel identifies variants in genes linked to a number of cancers, including acute myeloid leukemia, myeloid proliferative neoplasm, myeloid dysplastic syndrome, and myeloid dysplastic/myeloid proliferative overlap disorders. 

Jan 22, 2019

AusDiagnostics Dermatophytes IVD Kit

AusDiagnostics has released a new in vitro diagnostic kit that detects dermatophytes and other fungi. According to the firm, the new kit will produce a result in four hours, allowing medical professionals to advise their patients on the best course of treatment. AusDiagnostics said that the kit detects species of Microsporum, Trichophyton, and Epidermophyton, as well as typing six common dermatophytes and six Candida speices. 

Jan 22, 2019

Horizon Discovery CRISPR Screening Service for Primary Human T Cells

Horizon Discovery has extended its CRISPR Screening Service to include ex vivo T lymphocytes. Horizon has adapted its established CRISPRko (knockout) platform to screen human T lymphocytes, adding CRISPRko screens in ex vivo T lymphocytes to its established CRISPR screening formats – CRISPRko, CRISPRi (interference) and CRISPRa (activation) – in cancer cell lines. The service extension meets the requirements of immunology-based research in drug discovery, allowing for the identification of new gene targets in biologically and potentially therapeutically relevant settings, the firm said.

 

Jan 16, 2019

HTG Molecular EdgeSeq Reveal

HTG Molecular today launched its HTG EdgeSeq Reveal software. According to the firm, the software streamlines biomarker data analysis from samples analyzed with the HTG EdgeSeq Precision Immuno-Oncology Panel on its EdgeSeq system. When used with the panel, the software allows applications including immunophenotyping of tumor infiltration lymphocytes, monitoring of immunotherapy response biomarkers, and elucidating immune-escape mechanisms know to drive disease progression. The firm noted that users will be able to conduct molecular profiling using a wide variety of sample types, potentially allowing them to support translational applications and determine potential biomarkers for companion diagnostic development. 

Jan 16, 2019

Oxford Nanopore Field Sequencing Kit

Oxford Nanopore Technologies has launched a Field Sequencing Kit for sequencing library preparation from genomic DNA that requires no refrigeration. The kit requires 400 nanograms of high molecular weight DNA as input, and generates libraries in 10 minutes using a two-step protocol. A transposase simultaneously cleaves template molecules and attaches tags to their ends. After that, rapid sequencing adapters are added to the tagged ends. The unopened kit is shipped cold and is stable for up to one month at 30° C and up to three months at 2° C to 8° C.

Jan 14, 2019

NRGene, Macrogen ArrayMagic

NRGene and Macrogen have launched a joint sequencing-based genotyping service called ArrayMagic, which the firms said provides ultra-high-density SNP genotying at a low cost per datapoint. As part of the service, the team will launch a dedicated website to advise customers on how to send samples to Macrogen. The partners then employ a sequencing library prep method, developed by iGenomX, to create an ultra-low coverage sequencing dataset for each sample. NRGene then applies its database and analytical tools to impute a high-resolution SNP set from the data. 

Jan 11, 2019

TATAA Biocenter Alu Assays

TATAA Biocenter is now offering ultra-sensitive qPCR assays targeting human-specific Alu repeats, which comprise about 10 percent of the human genome. The assays are available for different target lengths, which makes it possible to characterize the integrity of gDNA. The ration measured with TATAA ALU-60, which amplifies 60-bp targets, to TATAA ALU-187, which amplifies 187-bp targets, assesses the level and fraction of cell-free DNA in liquid biopsy samples. The assays can detect even miniscule amounts of human genomic DNA contamination, and contaminated reagents can be cleaned with the Heat/Run gDNA removal kit. The ALU quality control panel was in part developed for the CANCER-ID consortium, TATAA said.

Jan 09, 2019

Asuragen AmplideX PCR/CE HTT Kit

Asuragen said today that it has launched its AmplideX PCR/CE HTT kit. The tool detects CAG trinucleotide repeats within the HTT gene, which are linked to the development of Huntington disease. According to the firm, the kit offers a streamlined, single-well PCR workflow that allows researchers to detect and size expansions with greater than 200 CAG repeats in about six hours. The kit provides all necessary reagents to size the expansion using 10 ng of DNA isolated from whole blood samples. The assay also addresses sample zygosity and preserves the CAG repeat profile in the presence of adjacent SNPs. The assay runs on Thermo Fisher Scientific Applied Biosystems Genetic Analyzers, including the 3130, 3500, and 3700 platforms.

Jan 08, 2019

Yourgene Sage 32 Plex

Yourgene Health has launched the Sage 32 plex test, a high-throughput noninvasive prenatal testing and analysis solution for clinical laboratories. It runs on Thermo Fisher Scientific's Ion Torrent sequencing platform and allows 32 samples to be processed in parallel. The test, which will be available internationally, has improved performance due to workflow enhancements and upgraded analysis methods. Yourgene plans to launch a CE-IVD-marked version of the library preparation kit for the Sage 32 plex workflow in the coming months. The Sage test differs from Yourgene's other NIPT, the Iona test, in that it screens for a wider range of conditions, including trisomies 21, 18, and 13; sex chromosome aneuploidies; and clinically relevant microdeletions. The analysis uses a cloud-based bioinformatics solution called Sage Link.

Jan 07, 2019

Twist Bioscience Synthetic DNA, TAPI

Twist Bioscience is now offering to synthesize genes up to five kilobases in length for $0.15 per base pair and with a turnaround time of 15 to 25 days. In addition, the company is making its Twist Application Programming Interface (TAPI) available to all customers ordering synthetic DNA.

Jan 04, 2019

PreventionGenetics Patient Plus

PreventionGenetics announced that it has added the Patient Plus feature to its PGxome whole-exome sequencing tests. Patient Plus invovles sequencing and copy number variant analysis, as well as targeted testing for the key sequence variants in a patient's parental specimens. According to PreventionGenetics, the approach allows researchers to detect de novo variants and phasing of variants in recessive genes.

Dec 21, 2018

Contextual Genomics 'Find It' and 'Follow It' Assays

Contextual Genomics, a Vancouver, Canada-based cancer genomics company, said that it has completed development of two new products: an improved version of its Find It hotspot panel for detection of genomic mutations in solid tumour cancers; and its Follow It hotspot panel for detection of the same genomic mutations in blood plasma.

The Find It panel now screens for 146 somatic genome alterations found in solid tumor cancers to identify optimal therapeutic treatments and recognize acquired drug resistance mutations. The assay is supported by Contextual's cloud-based genome analysis engine (CGIRP).

The Follow It panel screens for cell-free circulating tumour DNA in plasma, and is designed to  be used in patients with widespread metastatic disease at diagnosis and as a time series monitoring tool to read out tumor burden and treatment resistance. Follow It will screen for all of the same somatic genome alterations as Find It and can be used to follow disease progression for patients, including those whose tumors were initially tested with Find It.

Dec 21, 2018

DiaSorin Molecular Primer Pairs

DiaSorin Molecular has introduced three new primer pairs for Legionella species, Chlamydophila pneumoniae, and Mycoplasma pneumoniae, which can be used in laboratory-developed tests. The firm noted that it now offers more than 55 analyte-specific reagents.

Dec 20, 2018

Viracor Eurofins 16S NGS Bacterial Meningitis Test

Viracor Eurofins recently launched its 16S Next-Generation Sequencing Bacterial Meningitis test. The assay amplifies the 16S gene utilizing PCR, followed by NGS to identify and report the bacterial pathogen in a patient's CSF sample. The assay was validated to include the most common bacterial pathogens associated with meningitis: Streptococcus pneumoniae, Neisseria meningitidisHaemophilus influenzaeListeria monocytogenesStreptococcus agalactiae (Group B Strep), and Escherichia coli, as well as other less common pathogens that may be clinically important in immunocompromised patient populations (HIV-positive, solid organ transplant, or hematopoietic cell transplant patients). Physicians will receive test results for difficult-to-diagnose immunocompromised patients within three business days from specimen receipt, the company said.

Dec 19, 2018

Lexogen TeloPrime Full-Length cDNA Amplification Kit V2

Lexogen has launched a new version of its TeloPrime Full-Length cDNA Amplification Kit. TeloPrime allows detection and correct quantification of splice variants and their "true transcription start- and end-sites, in both short and long mRNA molecules," the firm said. According to Lexogen, the upgraded kit provides higher yields and enhanced representation of longer cDNAs from as little as 1 nanogram of RNA. 

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.